Edward T. Anderson, Director, 10% Owner at Lyra Therapeutics, Inc. (LYRA), bought 4,976,300 shares at $4.22 ($21.0M) on 2022-04-12, disclosed to the SEC on 2022-04-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.22 | 118,483 | $500K | 2.4% |
| 2 | $4.22 | 118,483 | $500K | 2.4% |
| 3 | $4.22 | 527,806 | $2.2M | 10.6% |
| 4 | $4.22 | 527,806 | $2.2M | 10.6% |
| 5 | $4.22 | 765,010 | $3.2M | 15.4% |
| 6 | $4.22 | 765,010 |
| $3.2M |
| 15.4% |
| 7 | $4.22 | 1,076,851 | $4.5M | 21.6% |
| 8 | $4.22 | 1,076,851 | $4.5M | 21.6% |
| Total | $4.22 avg | 4,976,300 | $21.0M | 100% |
| Filing → |
| BASE | BUY | 2021-07-26 | $4.0M | — | Filing → |
| LYRA | BUY | 2020-05-06 | $4.0M | — | Filing → |
| LYRA | SELL | 2020-05-06 | $387K | — | Filing → |